Experts in dermatology discuss practical and clinical considerations in the utilization of JAK inhibitors in the management of patients suffering from atopic dermatitis.
Optimizing Patient Outcomes with JAK Inhibitors
Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
Efficacy and Safety of JAK inhibitors for AD
Experts in atopic disease management review the efficacy and safety data of the JAK inhibitor class, highlighting the importance of time to treatment response and itch reduction.